XJPX
9989
Market cap2.64bUSD
Oct 09, Last price
3,530.00JPY
1D
-0.81%
1Q
-7.08%
Jan 2017
-12.73%
Name
Sundrug Co Ltd
Chart & performance
P/E
13.15
P/S
0.49
EPS
268.35
Div yield, %
3.65%
Shrs. gr., 5y
0.01%
Rev. gr., 5y
5.84%
Revenues
842.51b
+5.08%
Net income
31.39b
+2.09%
CFO
43.30b
+5.18%
Dividend
Mar 31, 202766 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sundrug Co.,Ltd. engages in the drug store business in Japan. It operates through Drug Store Business and Discount Store Business segments. The Drug Store Business segment primarily sells pharmaceutical products, cosmetics, and daily necessities. The Discount Store Business segment offers food and household goods. The company was incorporated in 1957 and is headquartered in Fuchu, Japan.
Key people
Hiroshi Sadakata
President, Chief Executive Officer, Chairman of Subsidiary, Representative Director · since 2022
Koichi Ura
Executive Officer, Chief Director of Sales · since 2024
Yoshinobu Kato
Executive Officer, Chief Director of Administration · since 2022
Kazuhiro Yamauchi
Executive Officer, Chief Director of Product · since 2024
Yoshimitsu Sakai
Chief Director of Store Development, Director · since 2022
Takashi Tada
Director · since 2024
Naoki Tada
Chairman, Director · since 2022
Masato Matsumoto
Independent Director · since 2018
Ritsuko Saito
Independent Director · since 2024
Independent Director · since 2020
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||